Dare Bioscience, Inc.

0.43 USD
-0.00 (-0.69%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Dare Bioscience, Inc. stock is down -4.11% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 45.45% of the previous 10 June’s closed higher than May.

About Dare Bioscience, Inc.

Daré Bioscience, Inc. develops therapies in the areas of contraception, fertility, and sexual and vaginal health. Its product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its products in advanced clinical development include Ovaprene, a hormone-free monthly vaginal contraceptive.